Galmed Pharmaceuticals Ltd (GLMD)
0.3874
0.00 (0.00%)
USD |
NASDAQ |
May 03, 16:00
0.40
+0.01
(+3.25%)
After-Hours: 20:00
Galmed Pharmaceuticals Shareholders Equity (Quarterly): 13.88M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 13.88M |
| September 30, 2023 | 15.55M |
| June 30, 2023 | 10.55M |
| March 31, 2023 | 11.99M |
| December 31, 2022 | 13.42M |
| September 30, 2022 | 15.75M |
| June 30, 2022 | 20.71M |
| March 31, 2022 | 24.37M |
| December 31, 2021 | 30.50M |
| September 30, 2021 | 37.68M |
| June 30, 2021 | 45.00M |
| March 31, 2021 | 52.96M |
| December 31, 2020 | 44.15M |
| September 30, 2020 | 53.66M |
| June 30, 2020 | 59.88M |
| March 31, 2020 | 64.10M |
| December 31, 2019 | 69.85M |
| September 30, 2019 | 77.42M |
| June 30, 2019 | 81.39M |
| March 31, 2019 | 84.93M |
| December 31, 2018 | 87.89M |
| Date | Value |
|---|---|
| September 30, 2018 | 90.75M |
| June 30, 2018 | 91.04M |
| March 31, 2018 | 13.60M |
| December 31, 2017 | 15.80M |
| September 30, 2017 | 6.532M |
| June 30, 2017 | 6.242M |
| March 31, 2017 | 8.298M |
| December 31, 2016 | 11.08M |
| September 30, 2016 | 15.53M |
| June 30, 2016 | 14.43M |
| March 31, 2016 | 17.88M |
| December 31, 2015 | 21.54M |
| September 30, 2015 | 25.06M |
| June 30, 2015 | 27.42M |
| March 31, 2015 | 29.49M |
| December 31, 2014 | 31.41M |
| September 30, 2014 | 33.25M |
| June 30, 2014 | 36.35M |
| March 31, 2014 | 37.95M |
| December 31, 2013 | -1.951M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
10.55M
Minimum
Jun 2023
81.39M
Maximum
Jun 2019
39.10M
Average
37.68M
Median
Sep 2021
Shareholders Equity (Quarterly) Benchmarks
| Compugen Ltd | 65.56M |
| Pluri Inc | 4.399M |
| BioLine Rx Ltd | 13.22M |
| Can Fite Biofarma Ltd | 6.243M |
| BiomX Inc | 3.081M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 16.63M |
| Total Liabilities (Quarterly) | 2.75M |